Search
Invitrogen
CD158a/h/g Monoclonal Antibody (HP-MA4)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
Product Details
MA562208
Applications
Tested Dilution
Publications
Product Specifications
Species Reactivity
Human
Host/Isotype
Mouse
/ IgG2b, kappa
Class
Monoclonal
Type
Antibody
Clone
HP-MA4
Immunogen
Human NK cell line LB2.
Conjugate
Form
Liquid
Concentration
1 mg/mL
Amount
100 µg
Purification
Protein A
Storage buffer
PBS, pH 7.4
Contains
15mM sodium azide
Storage conditions
4°C, do not freeze
Shipping conditions
Ambient (domestic); Wet ice (international)
RRID
Target Information
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes. The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
References (0)
Have you cited this product in a publication?
Let us know so we can reference it here.
Bioinformatics
Protein Aliases: CD158; CD158 antigen-like family member A; CD158 antigen-like family member D; CD158 antigen-like family member G; CD158 antigen-like family member H; CD158 antigen-like family member I; CD158 antigen-like family member J; CD158a; CD158B1; CD158d; CD158g; CD158h; CD158i; CD158j; extracellular domain; G9P; Ig1-TM10A; Ig1-TM10A truncated; Ig2-TM9A Del; Killer cell immunoglobulin-like receptor 2DL1; Killer cell immunoglobulin-like receptor 2DL4; Killer cell immunoglobulin-like receptor 2DS1; Killer cell immunoglobulin-like receptor 2DS2; Killer cell immunoglobulin-like receptor 2DS4; Killer cell immunoglobulin-like receptor 2DS5; killer cell immunoglobulin-like receptor KIR2DS2; killer cell immunoglobulin-like receptor KIRDS1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; Killer cell inhibitory receptor 103AS; killer cell inhibitory receptor homolog; KIR homolog; killer Ig receptor; killer inhibitory receptor 2-2-1; killer inhibitory receptor 4-1-2; killer-cell Ig-like receptor; killer-cell immunoglobulin-like receptor; killer-cell immunoglobulin-like receptor two domains short tail 2 protein; KIR antigen 2DS4; KIR cl-17; killer cell inhibitory receptor; KIR-103AS; KIR2DL protein; KIR2DL1/3DL2; KIR2DL4; KIR2DL4 Killer-cell Immunoglobulin-like Receptor; KIR2DL4*00102; KIR2DL4*00103; KIR2DL4*00501; KIR2DL4*00801; KIR2DL4*00802; KIR2DL4*01101; KIR2DL4*021; KIR2DL4*022; KIR2DL4_00201; KIR2DL4_00201 protein; KIR2DS1 Killer-cell Immunoglobulin-like Receptor; KIR2DS2 Killer-cell Immunoglobulin-like Receptor; MHC class I NK cell receptor; MHC class I NK cell receptor Eb6 ActI; MHC class I NK cell receptor KIR103AS; natural killer associated transcript 5; natural killer cell inhibitory receptor; natural killer cell receptor; Natural killer-associated transcript 1; Natural killer-associated transcript 5; Natural killer-associated transcript 8; Natural killer-associated transcript 9; NK cell receptor; CD158d; NK receptor 183 ActI; NKAT-1; NKAT-5; NKAT-8; NKAT-9; NKAT5-delta-Ig1/Ig2; putative; nkat5-delta-Ig1; putative; NKAT6; nkat8; putative; nkat9; putative; p50 KAR; p50 killer cell activating receptor KAR-K1d; p50.3; p58 killer cell inhibitory receptor KIR-K64; p58 killer cell inhibitory receptor KIR-K7a; p58 KIR; p58 natural killer cell receptor clone CL-49; P58 natural killer cell receptor clones CL-39/CL-17; p58 natural killer cell receptor clones CL-42/47.11; p58 NK cell inhibitory receptor NKR-K6; p58 NK receptor CL-39/CL-17; p58 NK receptor CL-42/47.11; p58 NK receptor CL-49; p58.1 MHC class-I-specific NK receptor; short cytoplasmic tail variant; XXbac-BCX195L8.1
Gene Aliases: 183ActI; CD158A; CD158b; CD158D; CD158G; CD158H; CD158I; CD158J; cl-49; G9P; KIR-103AS; KIR-2DL4; KIR-2DS2; KIR-2DS4; KIR-K64; KIR103; KIR103AS; KIR1D; KIR221; KIR2DL1; KIR2DL3; KIR2DL4; KIR2DS1; KIR2DS2; KIR2DS4; KIR2DS5; KIR412; KKA3; NKAT; NKAT-1; NKAT-5; NKAT-8; NKAT1; NKAT5; NKAT8; NKAT9; p50.1; p58.1
UniProt ID: (Human) P43626, (Human) Q99706, (Human) Q14954, (Human) P43631, (Human) P43632, (Human) Q14953
Entrez Gene ID: (Human) 3802, (Human) 3805, (Human) 3806, (Human) 100132285, (Human) 3809, (Human) 3810
stimulatory killer cell immunoglobulin-like receptor signaling pathway
immune response-regulating signaling pathway
immune response
natural killer cell inhibitory signaling pathway
positive regulation of natural killer cell cytokine production
cellular defense response
signal transduction
negative regulation of natural killer cell mediated cytotoxicity
positive regulation of cellular senescence
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Performance Guarantee
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support